KEP Korea posts 10 percent Q4 2025 EPS miss shares rise modestly as investors look past weak results Aquestive AQST Stock Mandatory Convertible Smart Money Flows 20260420 BBNX Beta Bionics posts narrower Q4 2025 loss than analyst estimates strong year over year revenue growth lifts shares slightly BKHAR Black Hawk releases quarterly earnings report with no finalized revenue or EPS metrics available at this time Is SKYX Platforms SKYX stock exposed to downside movement SKYX Platforms posts 148 EPS miss on wider loss Ivan J Presant Joins Lowenstein Sandler as MA Partner Strengthening Transactions Advisory Group ICF International ICFI Stock Today Rallies 285 Resistance at 6600 20260518 Newmont NEM Falls 178 Watching 11100 Support 20260514 Dave PLAY Q1 2026 Results Fall Short EPS 115 Revenue NA Quantum Computing Industry Poised for 72 Billion Growth Key Players and Market Dynamics Saratoga Investment Corp 850 Notes SAZ Edges Higher Amid Steady Trading HF Foods HFFG Q1 2026 Earnings EPS 006 Beats Estimates Axos AX Q1 2026 Beat Revenue NA EPS Exceeds by Significant Japan Shipbuilding Town Turns to Foreign Workers and AI to Address Labor Shortage Snap Inc SNAP Earnings Wall Street Remains Cautious on Growth Outlook AnheuserBusch InBev Shares Dip on Sales Miss Market Cautious Trumps 230M Legal Claim Raises Governance Concerns and Market Stability Questions AI Gurus Charge Wall Street Banks 25000 a Day for Advisory Services BJs Wholesale Announces Major Store Changes Amid Consumer Spending Slowdown ASR Q1 2026 Earnings EPS Misses Estimates as Operational Challenges Weigh MDXH Q1 2026 Earnings EPS Miss and Negative Surprise Weigh on Shares WFC Q1 2026 Earnings Narrow EPS Beat Lifts Shares as Revenue Picture Remains Unclear LEXX Q1 2026 Earnings Narrower Loss Surprises as Bioscience Firm Advances Drug Delivery Pipeline GH Q1 2026 Earnings NarrowerThanExpected Loss Lifts Shares Slightly Amazon and GE Vernova Among Stocks Approaching Key Levels as Market Strength Persists C4 Therapeutics Q1 2026 Earnings EPS Surprises to the Upside as Biotech Focuses on Pipeline Execution